The results of studies on this issue indicated that the downregulation of RASA1 is directly related to the overexpression of miR-182, thus it was suggested that miR-182 can promote HCC cell angiogenic ability by targeting RASA1 [62]. The gene discussed is RASA1; the disease is hepatocellular carcinoma.